-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Ironwood Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2024.
- Ironwood Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $13.7M, a 23.7% decline year-over-year.
- Ironwood Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $74.7M, a 0.13% decline year-over-year.
- Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $83.5M, a 7.93% increase from 2022.
- Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $77.4M.
- Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$328M, a 12308% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)